PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of share options/ director dealing

20 Apr 2017 07:00

RNS Number : 7731C
LiDCO Group Plc
20 April 2017
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Award of share options/director dealing

 

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that the Board has yesterday, 19th April 2017, finalised a grant of options ("Options") to Mr Sassone, CEO, to subscribe for new ordinary shares of 0.5p each ("Ordinary Shares").

 

 

Option type

Number of shares over which options granted

Total number of options held post grant

Percentage of issued share capital under option

Matt Sassone

EMI

3,448,262

3,448,262

1.4%

 

Unapproved

3,147,342

3,147,342

1.3%

 

 

 

 

 

 

 

 

 

 

Total

 

6,595,604

6,595,604

2.7%

 

The above Options vest and may be exercised from between fourteen months and three years from grant if certain share price hurdles are met. The Options are exercisable over a range of periods at 0.5 pence per Ordinary Share, subject to the Company's share price averaging above a number of hurdle rates. Expiry dates range from April 2022 to June 2025. The hurdle rates were in part set with regard to the placing price of 6p in December 2016 and are between 8p and 15p. Full details are given in the Company's report and accounts (Directors' remuneration report) which are available on the Company's website.

 

Simultaneous with this grant, 4,395,604 options have lapsed and been cancelled. The total number of shares under option following these grants is therefore 14,990,087 representing 6.1% of the issued share capital.

 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Matt Sassone

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

n/a

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5p nominal

 

GB0030546849

b)

Nature of the transaction:

Grant of Management Share Options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

0.5p

6,595,604

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

0.5p

6,595,604

e)

Date of the transaction:

19/04/17

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

For further information, please contact:

 

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tel: +44 (0)20 7749 1500

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Emily Watts (Corporate Finance)

Stephen Norcross (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Lianne Cawthorne

Mob: 07584 391 303

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEKLFFDZFFBBD
Date   Source Headline
12th Feb 20207:00 amRNSHolding(s) in Company
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSBlock Listing Review
18th Nov 20199:32 amRNSDirector/PDMR Shareholding
7th Nov 201910:30 amRNSLiDCO to present at Mello London, 2019
5th Nov 20197:00 amRNSLatest monitor launched in China
16th Oct 20197:00 amRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSHalf-year Report
12th Sep 20197:00 amRNSCapital Markets Day & technology agreement
20th Aug 20197:00 amRNSCapital Markets Day
20th Aug 20197:00 amRNSTrading update & Notice of results
15th Aug 20197:00 amRNSAppointment of Non-Executive Director
1st Aug 20197:00 amRNSBlock Listing Review
16th Jul 20197:00 amRNSRegulatory approval in China
16th May 201910:30 amRNSResult of AGM
16th May 20197:00 amRNSAGM Statement
23rd Apr 20197:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
17th Apr 20197:00 amRNSRegulatory approval in South Korea
16th Apr 20197:00 amRNSAward of share options/director dealing
2nd Apr 20197:00 amRNSDirector/PDMR Shareholding
1st Apr 20195:48 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSFinal Results
12th Mar 20197:00 amRNSMaster distribution agreement for Latin America
8th Mar 20197:00 amRNSHUP progress update
5th Mar 20197:00 amRNSDirectorate Change
20th Feb 20195:00 pmRNSHolding(s) in Company
20th Feb 20197:00 amRNSPre-Close Trading Update and Notice of Results
1st Feb 20197:00 amRNSBlock Listing Review
17th Dec 20187:00 amRNSTrading update and notice of results
12th Oct 201811:20 amRNSHolding(s) in Company
9th Oct 20187:01 amRNSHalf-year Report
9th Oct 20187:00 amRNSUK distribution agreement with Shenzhen Antmed
24th Sep 20187:00 amRNSDirectorate Change
20th Aug 20182:58 pmRNSHolding(s) in Company
20th Aug 20187:00 amRNSTrading update & Notice of results
1st Aug 20188:41 amRNSBlock listing Review
19th Jul 20187:00 amRNSUK distribution agreement with Maicuff Technology
29th Jun 20187:11 amRNSAward of share options/director dealing
17th May 201810:36 amRNSResult of AGM
17th May 20187:00 amRNSAGM Statement
16th May 20187:00 amRNSCapital Markets Day & US progress update
24th Apr 20187:00 amRNSCapital Markets Day
24th Apr 20187:00 amRNSPosting of Annual Report & Accounts& Notice of AGM
10th Apr 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSEnd of third party UK Distribution agreement
22nd Feb 20187:00 amRNSAppointment of French distributor
15th Feb 20187:01 amRNSTrading update and notice of results
15th Feb 20187:00 amRNSSignificant US & UK HUP wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.